Status:
COMPLETED
Assessing QbTest Utility in ADHD: A Randomised Controlled Trial
Lead Sponsor:
University of Nottingham
Collaborating Sponsors:
National Institute for Health Research, United Kingdom
Conditions:
Attention Deficit Hyperactivity Disorder (ADHD)
Eligibility:
All Genders
6-17 years
Phase:
NA
Brief Summary
Attention Deficit/Hyperactivity Disorder (ADHD)is one of the most common mental health disorders of childhood. Children with ADHD often have poor attention, are restless and hyperactive and show impul...
Eligibility Criteria
Inclusion
- Age 6-17 years (may turn 18 years during the study).
- Referred to CAMHS or community paediatrics for an ADHD assessment
- Capable of providing written informed consent (over 16)
- Parental consent (under 16)
Exclusion
- Non-fluent English
- Suspected moderate or severe learning disability
- Previous or current diagnosis of ADHD
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
267 Patients enrolled
Trial Details
Trial ID
NCT02209116
Start Date
July 1 2014
End Date
June 1 2016
Last Update
June 22 2016
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Central Manchester University Hospitals NHS Foundation Trust
Manchester, Greater Manchester, United Kingdom, M13 9WL
2
Medway NHS Foundation Trust
Gillingham, Kent, United Kingdom, ME7 5NY
3
Bridgewater Community Healthcare NHS Trust
Wigan, Lancashire, United Kingdom, WN3 6PR
4
Leicestershire Partnership Nhs Trust
Leicester, Leicestershire, United Kingdom, LE5 0TD